Nichi-Iko to Set up Biosimilar Dept. in October to Push Remicade Follow-On

Nichi-Iko Pharmaceutical will establish a department responsible for marketing biosimilars and collecting information related to these products on October 1 as part of its organizational change, it said on September 20. The Japanese generic major envisages winning approval for a...read more